The Battle of Brands vs Generics in Controlling Drug Benefits Costs: Patents & Exclusivity Periods
This is part one of a two-part series on how brand and generic drug manufacturers battle for market share.See part...
Clinical Team's Posts
What Are Orphan Drugs, Biologics, and Biosimilars?
Over the last decade, the shift in drug mix from generic to specialty has changed how plan sponsors must manage...
Specialty Medication Dose Creep: What It Is and How to Avoid It
As more high-cost specialty prescription drugs come to market, self-funded employers will continue to be challenged by managing specialty medications...
What Employers Need to Know About Lasting COVID-19 Complications & Rx Costs
A year has passed since the COVID-19 pandemic began, and we are learning more every day about the virus and...
